The most commonly mutated genes in the Xuanwei NSCLC cohort were TP53 (51%), EGFR (49%), KRAS (28%), LRP1B (26%), and SPTA1 (23%) (Figure 3A). This evidence concerns the gene EGFR and non-small cell lung carcinoma.